Publications by authors named "Ivan B Cheglakov"

Claim this Profile
C
Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Lyudmila S Krassikova, Saida S Karshieva, Ivan B Cheglakov, Alexander V Belyavsky

J Gene Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice.
Philipp O Tsvetkov, Ivan B Cheglakov, Armen A Ovsepyan, Oleg Y Mediannikov, Alexander O Morozov

J Alzheimers Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.
Alexandra A Kulikova, Ivan B Cheglakov, Michail S Kukharsky, Ruslan K Ovchinnikov, Sergey A Kozin

Neurotox Res· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripherally applied synthetic tetrapeptides HAEE and RADD slow down the development of cerebral β-amyloidosis in AβPP/PS1 transgenic mice.
Philipp O Tsvetkov, Ivan B Cheglakov, Armen A Ovsepyan, Oleg Y Mediannikov, Alexander O Morozov

J Alzheimers Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis